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Background: Cardiac autonomic neuropathy (CAN) is a common complication of type 2 diabetes mellitus (T2DM).
Brachial-ankle pulse wave velocity (baPWV) is known to be a good surrogate marker of vascular damages. The goal
of this study was to investigate the relationship between BaPWV and CAN in T2DM.
Methods: A total of 148 patients who had no apparent history of cardiovascular condition were enrolled consecutively
in this study. The correlation between increased baPWV and CAN was analyzed. CAN was evaluated by five standard
cardiovascular reflex tests (CARTs) according to the Ewing's protocol: 1) heart rate variation during deep breathing, 2)
heart rate response to standing, 3) Valsalva maneuver, 4) postural systolic blood pressure (BP) change, 5) Sustained
handgrip test. CAN was defined as the presence of at least two abnormal tests.
Results: The mean age of patients was 59.8 ± 7.8 years. The mean duration of diabetes was 6.0(2.0-11.0) years. The
mean baPWV was 1665.5(1482.0-1940.0) cm/sec. Subjects with CAN were older and had high BMI, baPWV compared
with those without CAN. The proportion of patients with diabetic peripheral neuropathy was higher in subjects with
CAN. After adjusting for other confounding risk factors, baPWV (odds ratio = 8.496, 95% CI: 1.216-59.348; P = 0.031)
remained as independent risk factors for CAN. The number of abnormal CARTs increased gradually with increasing
baPWV (correlation coefficient =0.255, p = 0.002).
Conclusion: Increased baPWV was significantly correlated with CAN in patients with type 2 diabetes.
Keywords: Cardiac autonomic neuropathy, Brachial-ankle pulse wave velocity, Type 2 diabetesIntroduction
Cardiovascular autonomic neuropathy (CAN) is a serious
complication of diabetes, which was associated with
cardiovascular morbidity and all-cause mortality in people
with Type 2 diabetes mellitus [1,2]. CAN was caused by
damage to the autonomic nerve fibers that innervate
the heart and blood vessels. It leads to dysfunctional
heart-rate control and abnormal vascular dynamics,
which will increase heart rate variability and decrease
myocardial perfusion [3].
Pulse wave velocity (PWV) is known to be an indicator
of arterial stiffness and a surrogate marker of vascular
damages [4]. As brachial-ankle PWV (baPWV) is affected* Correspondence: renminghu@hotmail.com
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unless otherwise stated.by vasomotor reflexes, it can reflect the statements of
the aorta and peripheral arteries. The baPWV has been
thought to have a great association with micro-angiopathic
conditions and diabetes complications [5]. Previous reports
indicated that baPWV is used as a severity index for
subclinical atherosclerosis [6], and has been recommended
as test for the assessment of target organ damage in arterial
hypertension [7]. Aso et al. showed that baPWV was dir-
ectly related to the frequencies of albuminuria, autonomic
neuropathy, peripheral neuropathy, and retinopathy [5].
Bagherzadeh et al. reported that there exists a significant
relationship between heart rate variability (HRV) and
baPWV in diabetic patients [8].
This study used a retrospective analysis to investigate
CAN in type 2 diabetes patients and the association
between baPWV and cardiovascular autonomic reflex
tests (CARTs).. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Study subject
We enrolled consecutive type 2 diabetes subjects (mean
age. 59.8 years) who presented to outpatient department
of endocrinology at Huashan Hospital between August 1,
2012 and February 30, 2013. Exclusion criteria included
Type 1 diabetes characterized by a low C-peptide level
(<0.3 ng/ml) and a history of diabetic ketoacidosis, other
secondary causes of diabetes mellitus, malignancy, hepatic
failure, acute metabolic complications, fatal arrhythmia,
CVD such as acute coronary syndrome and previous
myocardial infarction, cervical spondylosis, infectious
polyneuritis, vasculitis, uremia, foot ulcers. Finally, 148
patients were enrolled in our study. Written informed
consents were obtained from all participants and the
study was approved by the local ethics committee of
the Huashan Hospital.
Data collection
A standardized questionnaire was designed to collect
clinical information regarding the duration of diabetes,
alcohol consumption, cigarette smoking and other health
related variables. Body weight and height were measured
with the participant wearing light clothing without shoes.
Body mass index (BMI) was defined as weight in kilogram
divided by square height in meter. Waist circumference
was measured at the narrowest point between the lower
limit of the ribcage and the iliac crest. Hip circumference
was measured around the widest portion of the buttocks,
with the tape parallel to the floor. Blood pressure (BP) was
measured in the supine position and in a resting state
using mercury sphygmomanometer with an appropriate
cuff on the left arm and the average of the last two
measurements was used.
A 12-hour overnight fasting venous blood sample
was collected for measurement of plasma glucose,
HbA1c, creatinine, total cholesterol, low-density lipo-
protein cholesterol (LDL-C), high-density lipoprotein
cholesterol (HDL-C), triglycerides (TG) using standard
protocol. First morning urine was collected once a day for
3 consecutive days. Albumin-to-creatinine radio was cal-
culated by dividing urinary albumin by urinary creatinine.
Cardiac autonomic function test
Patients were instructed to refrain from alcohol, tobacco,
caffeinated beverages and vigorous exercise during the
24 hours prior to the test. Before the test, the patients
would fast at least 3 hours. Medications such as β-
Blockers,antihistamines, antidepressants were withdrawn
for 12 hours prior to the test. All the tests were performed
by the same operator.
CAN was assessed by five standard cardiovascular
reflex tests according to Ewing’s protocol [9]. These
included heart rate (HR) responses to deep breathing(beat to beat variation), lying to standing HR responses
(30:15 ratio), Valsalva maneuver, blood pressure(BP)
responses to standing and sustained handgrip test. The
heart rate response to deep breathing, standing, and the
Valsalva maneuver were assessed automatically from elec-
trocardiography recordings using the Sunrui evaluation
system (ECG-2203B, Sunrui Co., Ltd., Guangzhou, China).
The severity of CAN was quantified by summing the
points obtained from each of the five tests, where each test
scored with 0, 0.5, or 1 points depending on whether it
yielded normal, borderline, or abnormal values, respect-
ively. CAN was defined as the presence of at least two
abnormal tests or autonomic neuropathy points ≥2 [10].
The CAN score was categorized as follows: CAN score 0
(total points 0), CAN score 1 (points 0.5 to 1.5), CAN
score 2 (points 2 to 3), and CAN score 3 (points ≥3.5).
CAN was considered absent, early, definite, or severe if
the CAN scores were 0, 1, 2, or 3, respectively.Measurements of baPWV
VP-1000 Automatic Arteriosclerosis Measurement System
(model BP-203 RPE-II, Colin Co, Ltd, Komaki, Japan) was
used to measure BaPWV. The details of the measurement,
validity, and reproducibility have been testified previously
[11]. The device can record pulse waves by sensors in four
cuffs, store data on the start point of each pulse wave
in the right arm and both legs, record the time difference
between transmission time to arm and transmission time
to ankle as “transmission time”, calculate the transmission
distance from the right arm to each ankle according to
body height, and automatically compute the baPWV
values by transmission time and transmission distance.
Patients were instructed to have a 5 min rest in a supine
position in a room with air-condition (24-26°C) before
test. There was a significant positive correlation between
left and right baPWV (r =0.953, P < 0.001). As a result, we
used a mean of bilateral baPWV value during analysis.Evaluation of diabetic microvascular complications
Diabetic retinopathy (DR) was defined based on digital
non-mydriatic fundus photography protocol which was
modified from procedures used in previous studies [12].
The patients were given 5 min in a darkened room to
allow dark adaptation. A trained photographer took a
single undilated non-mydriatic digital photograph centred
on the fovea of each fundus using a Canon CR6-45NM
camera, repeated once only if necessary. The digitally
stored fundus photographs were stored as bitmap im-
ages and viewed in a darkened room on CRT screens at
a resolution of 1024 × 768 pixels. The digitally stored
fundus images were graded by two endocrinologists and
a retinal specialist. Retinopathy was classified as either
absent or present.
Wu et al. Diabetology & Metabolic Syndrome 2014, 6:82 Page 3 of 8
http://www.dmsjournal.com/content/6/1/82The presence of diabetic nephropathy was defined as
microalbuminuria (creatinine 30–300 mg/g) or overt
albuminuria (creatinine > 300 mg/g). Urine albumin excre-
tion was determined by measuring the urine albumin:
creatinine ratio in spot urine samples [13].
Diabetic peripheral neuropathy (DPN) was assessed
using Neuropathy Deficit Score (NDS) and Neuropathy
Symptom Score (NSS). The diagnosis of DPN depends
on both subjective symptoms and signs of neuropathy.
We defined DPN as at least moderate signs with orTable 1 Clinical and biochemical characteristics of
participants
Characteristic N = 148
cardiovascular autonomic neuropathy(%) 78(52.7)
Age(years) 59.8 ± 7.8
Male,n(%) 80(54.0)
Current smoker, n (%) 43(29.0)
Alcohol consumption, n (%) 37(25.0)
Hypertension, n (%) 81(54.7)
Use of β-Blockers 34(22.9)
Use of ACEI/ARB 67(45.3)
Use of CCB 48(32.4)
Other antihypertensives 14(9.5)
Express as median(years) 6.0(2.0-11.0)
BMI(kg/m2) 24.4 ± 3.4
Waist-to-hip ratio 0.94(0.90-0.99)
systolic blood pressure(mmHg) 134.2 ± 18.1
diastolic blood pressure(mmHg) 78.3 ± 10.6
HbA1c(%) 8.0 ± 1.9
fasting glucose(mmol/l) 7.1(5.8-9.2)
Creatinine (μmol/L) 62.0(53.0-78.0)
eGFR( ml/min/1.73 m2) 107.0 ± 32.8






Diabetic retinopathy, n (%) 25(16.9)
Diabetic peripheral neuropathy, n (%) 46(31.1)
NSS score 5.0(2.0-6.0)
NDS score 4.0(2.0-5.0)
Diabetic nephropathy, n (%) 33(22.2)
BMI, body mass index; eGFR, modification of diet in renal disease study-glomerular
filtration rate; ACR, albumin-to-creatinine ratio;ACEI/ARB, angiotensin converting
enzyme inhibitors/Angiotensin II receptor blockers; CCB, Calcium channel blocker;
NSS, neuropathy symptom score; NDS, neuropathy disability score.
Data are means SD, median (25-75%), or number (percent).without symptoms (NDS ≥6), or mild signs with moderate
symptoms (NDS ≥3 and NSS ≥5) [14].Statistical analyses
Analyses were performed using IBM SPSS 19.0 for
Windows (SPSS Inc., an IBM company, USA). Numer-
ical variables with normal distribution are expressed
as means ± SD, and reported as median (interquartile
range) and log transformed to approximate normality
before analysis otherwise. Pearson correlational analysis
was used to examine the relationships between baPWV
and other metabolic variables in Type 2 diabetes. The
independent-samples t test or chi-squared tests were used
to compare the differences in clinical and biochemical
characteristics between patients with and those without
CAN. Multivariate logistic regression analyses were per-
formed to estimate the contribution of baPWV to cardiac
autonomic neuropathy using the odds ratio and 95% CI. P
values < 0.05 were considered statistical significant.Results
General characteristics of participants
The clinical and biochemical characteristics of the study
population are shown in Table 1. A total number of 148
Chinese (80 men and 68 women) were included. Mean age,
BMI and the duration of diabetes were 59.8 ± 7.8 years,
24.4 ± 3.4 kg/m2, and 7.2 ± 5.8 years, respectively. Mean
baPWV was 1665.5(1482.0-1940.0) cm/sec. Prevalence ratesTable 2 Correlation between baPWV and other clinical
variables
Variable Correlation coefficients P
Age 0.404 0.001
Duration of diabetes* 0.141 0.095
BMI 0.124 0.134
Waist-to-hip ratio* 0.081 0.327
systolic blood pressure 0.654 0.001
diastolic blood pressure(mmHg) 0.327 0.001
HbA1c −0.010 0.900
fasting glucose* 0.061 0.477
Creatinine* 0.020 0.832
eGFR −0.128 0.122
total cholesterol −0.038 0.694
Triglyceride* 0.151 0.116
LDL cholesterol* −0.028 0.779
HDL cholesterol* −0.073 0.459
ACR(mg/g) −0.028 0.781
Data are shown as Pearson correlation coefficients (r).
baPWV was log-transformed when statistics were applied.
*Denotes the variables that were log-transformed when statistics
were applied.
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neuropathy and diabetic nephropathy were 54.7, 16.9, 31.1
and 22.2%, respectively. Prevalence of hypertension was
54.7% and the information of anti-hypertensives use was
shown in Table 1. Furthermore, prevalences of early, defin-
ite and severe cardiac autonomic neuropathy were 39.2,
52.7 and 7.4%, respectively.Correlation between baPWV and other clinical variables
Table 2 shows the relationships between baPWV and
other clinical variables. baPWV was significantly corre-
lated with age (r = 0.404, p < 0.001) and systolic blood
pressure (r = 0.654, p < 0.001). Our results indicated that
baPWV was not associated with duration of diabetes,Table 3 Comparison of clinical characteristics according the p
Variable without CAN (n =
Age(years) 57.6 ± 7.6
Male,n(%) 41(58.6)
Current smoker, n (%) 17(24.3)
Alcohol consumption, n (%) 15(21.4)
Hypertension, n (%) 35(50.0)
Use of β-Blockers 16(22.9)
Use of ACEI/ARB 32(45.7)
Use of CCB 22(31.4)
Other antihypertensives 8(11.4)
Duration of diabetes(years)* 6.0(2.0-10.3)
BMI(kg/m2) 23.9 ± 3.1
Waist-to-hip ratio* 0.94(0.88-0.99)
systolic blood pressure(mmHg) 132.2 ± 16.4
diastolic blood pressure(mmHg) 78.7 ± 11.0
HbA1c(%) 7.9 ± 1.7
fasting glucose(mmol/l)* 7.1(6.0-9.1)
Creatinine (μmol/L)* 64.0(52.0-78.0)
eGFR( ml/min/1.73 m2) 107.8 ± 25.4






Diabetic retinopathy, n (%) 10(14.3)
Diabetic peripheral neuropathy, n (%) 16(22.9)
NSS score* 3.0(2.0-5.0)
NDS score* 3.0(2.0-4.0)
Diabetic nephropathy, n (%) 16(22.9)
BMI, body mass index; eGFR, modification of diet in renal disease study-glomerular
Data are means SD, median (25-75%), or number (percent).
*Denotes the variables that were log-transformed when statistics were applied.BMI, Waist-to-hip ratio, HbA1c fasting glucose, creatin-
ine, eGFR and lipid variables.
Characteristics of participants according to the presence
of cardiac autonomic neuropathy
Shown in Table 3, subjects with CAN were older and
had larger BMI(25.0 ± 3.6 vs. 23.9 ± 3.1, p = 0.042) and
higher baPWV(1722.0(1493.9-2040.8) vs. 1584.0(1446.1-
1812.63), p = 0.011). The prevalence of diabetic periph-
eral neuropathy was higher (38.5% vs 22.9%, p = 0.041)
and NSS score was higher in subjects with CAN. Other
microvascular complications including diabetic retinopathy
and diabetic peripheral neuropathy did not significantly
differ between the two groups. Duration of diabetes,
the presence of hypertension and other biochemicalresence of cardiac autonomic neuropathy
70) with CAN (n = 78) P value










25.0 ± 3.6 0.042
0.94(0.90-1.00) 0.849
136.0 ± 19.4 0.207
78.0 ± 10.3 0.691
8.1 ± 2.0 0.613
6.7(5.8-9.3) 0.750
59.0(53.0-79.5) 0.519
103.0 ± 31.1 0.303
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presence of CAN.
baPWV and CAN in patients with Type 2 diabetes
Age greater than 60 years old, BMI and baPWV were sig-
nificant risk factors for CAN (Model A in Table 4); how-
ever, adjusted for age, gender, duration of diabetes, BMI,
HbA1c, systolic blood pressure, the presence of diabetic
retinopathy, the independent risk factors remained baPWV
(odds ratio = 8.496, 95% CI 1.216–59.348; P = 0.031).
Remarkably, baPWV increased gradually with increasing
number of abnormal CARTs (Figure 1). The mean values
(SE) of baPWV significantly increased for those with one
to above three CARTs were 1647 (44.76), 1663 (36.82),
1911 (91.95) and 2076 (127.40) cm/sec after adjustment
for age (per decade), gender, smoking, duration of diabetes.
As shown in Table 5, baPWV was significantly higher in
patients with abnormal heart rate variation during deep
breathing and HR response to standing tests, compared to
patients with normal and borderline result tests while thereTable 4 Relationships between multiple risk factors and cardi
Variable Model A
Adjusted odds ratio (95%
Age > 60 years, no vs yes 2.247(1.160-4.349)
Gender(male) 1.513(0.776-2.951)
Duration of diabetes(per decade) 0.848(0.474-1.517)
BMI(per kg/m2) 0.888(0.800-0.985)
Waist-to-hip ratio* 2.205(0.014-353.823)
systolic blood pressure(per 10 mmHg) 1.008(0.989-1.027)
diastolic blood pressure(per 10 mmHg) 0.997(0.966-1.028)
Current smoker, no vs yes 1.660(0.792-3.479)
Alcohol consumption, no vs yes 1.521(0.702-3.292)
Hypertension, no vs yes 1.262(0.645-2.468)
HbA1c(per 1%) 1.115(0.929-1.338)
fasting glucose(per 1 mmol/l)* 1.020(0.922-1.128)
Creatinine (per 1 μmol/L)* 0.954(0.230-3.950)
eGFR( per 1 ml/min/1.73 m2) 0.999(0.987-1.011)
total cholesterol(per 1 mmol/l) 1.046(0.807-1.355)
Triglyceride(per 1 mmol/l)* 0.823(0.462-1.469)
LDL cholesterol(per 1 mmol/l)* 1.405(0.426-4.634)
HDL cholesterol(per 1 mmol/l)* 0.740(0.242-2.267)
ACR(mg/g) 1.000(0.999-1.000)
baPWV(cm/sec)* 6.117(1.032-36.245)
Diabetic retinopathy, no vs yes 1.431(0.586-3.493)
Diabetic peripheral neuropathy, no vs yes 2.071(0.994-4.315)
Diabetic nephropathy, no vs yes 0.940(0.426-2.072)
Data were obtained from a multivariate regression model.
Model A, adjusted for age; Model B, adjusted for age, gender, smoking, drinking, du
diabetic retinopathy.
*Denotes the variables that were log-transformed when statistics were applied.was no such difference observed regarding the valsalva
maneuver , postural BP change and sustained handgrip test.
After adjustment for age, gender and duration of diabetes,
the difference in baPWV between patients with normal and
abnormal tests remained significant for heart rate variation
during deep breathing (p = 0.002) and HR response to
standing tests (p = 0.046).Discussion
The present study demonstrates that baPWV was positively
associated with the prevalence of cardiac autonomic neur-
opathy in Type 2 diabetes. These relationships persisted in
the multivariate model after adjustment for known risk
factors. baPWV was known as a good surrogate markers
of clinical atherosclerosis and vascular dysfunction [4].
Our results suggested that CAN might be an important
factor of clinical atherosclerosis in T2DM. This finding of
the association between CAN and baPWV (a good sign of
vascular dysfunction) may help to explain the excessovascular autonomic neuropathy
Model B
























ration of diabetes, BMI, HbA1c, systolic blood pressure, the presence of
Figure 1 The levels baPWV according to the number of abnormal
CARTs. Data are shown as means ± SE after adjustment for age (per
decade), gender, smoking, duration of diabetes; P =0.002 for trend.
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subjects with CAN.
The main pathological findings for CAN are damages
to the autonomic nerve fibers that innervate the heart
and blood vessels and this resulted in abnormalities in
heart rate control and vascular dynamics [3]. Previous
studies have reported that CAN was associated with
accelerated atherosclerosis, represented as carotid intima
media thickness (CIMT) and plaques, independent of the
traditional cardiovascular risk factors in T2DM [15,16].
Therefore, the presence of CAN should be considered and
accessed when patients are in the early stage of diabetes,
rather than after the development of clinical cardiovascu-
lar disease.
Pulse wave velocity describes the rigidity of the arterial
wall, and is an indicator of atherosclerosis irrespective of
classical cardiovascular risk factors and ethnicity [17].
Many prospective studies showed that PWV had more
advantages in reflecting the risk of cardiovascular disease
than the blood pressure and had a strong relationship
with cardiovascular events and all-cause mortality [18].
As a simpler noninvasive method, brachial-ankle PWV
(baPWV) integrates the mechanical properties from both
the central and peripheral arteries. It has a high correl-
ation with traditional carotid-femoral PWV (cfPWV), and
it is suitable for general population studies [6]. PreviousTable 5 Mean baPWV value in patients with normal, borderlin
Normal result
baPWV(cm/sec)* HR variation during deep breathing 1537.50(1392.88-1863
HR response to standing 1623.75(1444.38-1890
Valsalva maneuver 1666.25(1459.88-1945
postural BP change 1651.75(1486.88-1937
Sustained handgrip test 1656.00(1500.13-1947
HR, heart rate; BP, blood pressure.
*Denotes the variables that were log-transformed when statistics were applied.
#P < 0.05, ##P < 0.01, for comparisons of baPWV values between abnormal, borderlistudies have indicated that baPWV was not only directly
related to macrovascular complications but also micro-
angiopathic conditions and diabetes peripheral neuropathy.
Yokoyama et al. reported that baPWV, retinopathy, age,
and glycated hemoglobin were independent risk factors
in DPN and the associated autonomic neuropathy [19].
Byung et al. reported that increased baPWV was signifi-
cantly correlated with peripheral neuropathy in patients
with type 2 diabetes which was diagnosed by total symptom
score (TSS) and abnormal neurological assessment [20]. As
to the relationship between baPWV and CAN, a recent
study [8] pointed out that the association between PWV
and CAN was independently significant in diabetes, which
used heart rate variability (HRV) as an index for CAN.
Our study further confirmed the association between
CAN and baPWV using CARTs as diagnosis criterion for
CAN. In a univariate analysis of the risk factors for CAN,
the odds ratio for baPWV was 6.117(95% CI, 1.032-36.245;
P = 0.046), which is a meaningful risk factor for CAN. A
multivariate logistic regression analysis was performed to
adjust for confounding variables and the adjusted odds ratio
was 8.496(95% CI, 1.216-59.348; P = 0.031), which indicates
that baPWV might be an independent risk factor for CAN.
Previous researches pointed out the primary factors
affecting baPWV are age, systolic blood pressure, and
gender [21]. In a Korean study on type 2 diabetes patients,
baPWV was significantly correlated with mean blood
pressure, heart rate, age, urine albumin/creatinine ratio
[22]. In our study, age, systolic blood pressure and dia-
stolic blood pressure were positive related with baPWV.
Duration of diabetes, BMI, glycated hemoglobin, lipid
levels were not correlated with baPWV. To our surprise,
urine albumin/creatinine ratio which have been proved to
be significantly associated with arteriosclerosis and auto-
nomic function [23,24] was not related with baPWV in
our study. That may be because 85.0% of our patients had
normal urine albumin/creatinine ratio which weaken the
link between urine albumin/creatinine ratio and baPWV.
According to our results, baPWV was significantly higher
in patients with abnormal heart rate variation during
deep breathing and HR response to standing tests. Both
heart rate response to deep breathing (deep breathing
test) and heart rate response to standing (standing test)e, and abnormal autonomic nervous function tests
Borderline result Abnormal result P for trend
.00) 1649.25(1480.75-1815.50) 1728.25(1524.00-2029.38)## 0.002
.00) 1757.25(1552.75-2012.75) 1825.00(1509.88-2020.63)# 0.046
.75) 1642.00(1512.25-2006.50) 1669.50(1445.25-1934.75) 0.392
.00) 1661.25(1426.50-1983.50) 1775.86(1568.67-2043.00) 0.471
.50) 1540.75(1329.37-1939.63) 1777.25(1509.88-1943.38) 0.835
ne and normal test.
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sympathetic activity of the heart innervation although the
sympathetic nervous system may somewhat affect these
reactions [3,25]. But heart rate variation during the Val-
salva maneuver and sustained handgrip test is mediated
by combined effect of parasympathetic and sympathetic
nerve fibres [3,26]. Our study showed that the increase
of baPWV better reflected the damage of parasympa-
thetic nerve fibres and for those CARTs who have a dual
innervation (parasympathetic and sympathetic nervous
system), the change of baPWV was insensitive. Our study
also demonstrated that the number of abnormal CARTs
increased gradually with increasing baPWV. In other
word, the surge of baPWV is a comprehensive reflec-
tion of injuries of the sympathetic nervous system and
the parasympathetic nervous system. The association be-
tween PWV and cardiac autonomic function also has
been examined in a small study in healthy individuals
[27]. Consistent with our results, heart rate response to
deep breathing showed moderate correlations with
PWV. CARTs mainly characterizing sympathetic func-
tion had no correlation with aortic stiffness parameters
including PWV.
The relationship between the decrease of large arteries
elasticity and the dysfunction of autonomic nervous
system in type 2 diabetes is not fully understood. It’s not
clear whether arterial stiffness produce dysfunction of
the cardiac autonomic nervous system or CAN induce
stiffness of the large arteries. Some study suggested that
dysfunction of the cardiovascular autonomic system may
influence the elasticity of the arterial wall by affecting the
vascular tone of large arteries [28]. Other studies indicated
that tachycardia which induced by CAN is main reason
for arterial stiffness. Indeed, increases in heart rate lead to
arterial stiffness independently of changes in activity of
the autonomic nervous system [29]. The present analysis
showed that there was correlation between heart rate
response to deep breathing, standing and baPWV, which
partly showed the association between parasympathetic
dysfunction and arterial stiffness.
The limitations of our study resulted from retrospective
cross-sectional design, which did not allow drawing
conclusions about any causal relation between CAN
and baPWV. We also could not assess how the changes
in both CARTs and baPWV through time, as well as
the changes in the serum glucose levels and glycosated
hemoglobin, affect each other. Secondly, our study was
conducted in outpatient department of endocrinology
and we formulated strict exclusion criteria. It largely
decreased the number of patients in our study. CART
tests required patients to actively cooperate with us and
the entire check need relatively long time. Many elderly
people and patients with severe diabetic complication
refused to participate in our study or dropped out fromthe study. So the participants in our study were younger
and had better health status, which means the conclusion
of our study may not be applied to other diabetes patients.
Moreover, the effects of the type of diabetes treatment and
other prescribed medications on CAN and PWV need to
be investigated in future studies.
In conclusion, CAN, particularly the injury of parasym-
pathetic activity of the heart, as expressed by abnormal
heart rate variation during deep breathing and standing,
correlates strongly with baPWV in patients with type 2
diabetes. Most interestingly, this finding was observed
in a population without apparent history of cardiovascular
condition.
Abbreviation
CAN: Cardiac autonomic neuropathy; baPWV: Brachial-ankle pulse wave
velocity; CARTs: Cardiovascular reflex tests; BP: Blood pressure; T2DM: Type 2
diabetes mellitus; HRV: Heart rate variability; HR: Heart rate; DR: Diabetic
retinopathy; DPN: Diabetic peripheral neuropathy; BMI: Body mass index;
eGFR: Modification of diet in renal disease study-glomerular filtration rate;
ACR: Albumin-to-creatinine ratio..
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